Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Sofosbuvir-velpatasvir-voxilaprevir

Brand: Vosevi®
NICE TA: 507
Indication: Chronic hepatitis C (NICE TA507)
Disease category: Infection
Commissioning responsibility: NHS England
PbR excluded: Yes

Background

Sofosbuvir–velpatasvir–voxilaprevir is recommended as an option for treating chronic hepatitis C in adults, only if it is used as specified in table 1 (see link below to NICE website) and the company provides the drug at the same price or lower than that agreed with the Commercial Medicines Unit.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA507 - Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red